Where the Money Goes
100% of Big Climb Seatle's proceeds go to the Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Since 1949, The Leukemia & Lymphoma Society (LLS) has been dedicated to curing leukemia, lymphoma and myeloma. LLS has been on the forefront of blood cancer advances such as chemotherapies and stem cell transplantation leading the way to the targeted therapies and immunotherapies that are saving thousands of lives today. LLS has changed the landscape of cancer with more than 300 active research projects that explore different avenues of new and adventurous research; ones with promise and ones that will save lives not someday, but today. Whenever we talk about cancer, we always use the same word. Someday. Someday there will be a cure. Someday we won’t lose the people we love. But when is someday? With LLS’s research partnerships and collaborations with pharmaceutical and biotechnology companies, patients support services and advocates working for blood cancer patients everywhere, someday is today.
Fred Appelbaum, M.D., Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center
"As a researcher in the field of blood cancers, I have never experienced a more exciting and hopeful time. We are in the midst of true revolutions in the areas of genomics and immunotherapy that almost certainly will bring us much closer to the long-sought goal of eliminating these diseases as a cause of suffering and death. It is, however, painfully ironic that at this very time, funding from the federal government for research in blood cancers has dropped. This is what makes support from the LLS so incredibly valuable. Without such support, dedicated investigators will be forced to leave the field, abandoning important avenues of research. Support from the LLS is critical to allow us to maintain the incredible momentum that has been built, so that we can see our current advances translated into clinical benefit."
More Financial Information (research spending, 990 tax forms, and annual reports)